Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

NCT07005180 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: HBI-002
DRUG: Vehicle (placebo)

Sponsor

Hillhurst Biopharmaceuticals, Inc.

Collaborators

[object Object]